Journal of Nuclear Medicine: 61 (2)

About the Cover

February 1, 2020; Volume 61,Issue 2

Cover image

FEATURED ARTICLE

Comparative Prognostic and Diagnostic Value of Myocardial Blood Flow and Myocardial Flow Reserve After Cardiac Transplantation. Robert Miller et al. See page 249.

⁵⁵Co-DOTATATE PET/CT: delayed imaging advantages in somatostatin-positive tumors. Thomas Andersen et al. See page 228.

In this issue

Issue highlights

Comparative Prognostic and Diagnostic Value of Myocardial Blood Flow and Myocardial Flow Reserve After Cardiac Transplantation
Improving Contrast and Detectability: Imaging with [⁵⁵Co]Co-DOTATATE in Comparison with [⁶⁴Cu]Cu-DOTATATE and [⁶⁸Ga]Ga-DOTATATE
The Spatial-Temporal Ordering of Amyloid Pathology and Opportunities for PET Imaging
FAP: The Next Billion Dollar Nuclear Theranostics Target?

⁶⁸Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer
Incidental Findings Suggestive of COVID-19 in Asymptomatic Patients Undergoing Nuclear Medicine Procedures in a High-Prevalence Region
Development of Fibroblast Activation Protein–Targeted Radiotracers with Improved Tumor Retention
First-in-Humans Imaging with ⁸⁹Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting
Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a ⁶⁸Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04

More...

Main menu

User menu

Search

About the Cover

Cover image

In this issue

Issue highlights

Jump to